Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Navit Naveh"'
Autor:
Raj Hanvesakul, Badri Rengarajan, Navit Naveh, Anne Boccuti, Julie E Park, Adekemi Adeyemi, Clyde Caisip, Jeroen P Jansen, Florence R Wilson
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 5 (2023)
Aim: Compare lurbinectedin versus other second-line (2L) small-cell lung cancer (SCLC) treatments. Methods: An unanchored matching-adjusted indirect comparison connected the platinum-sensitive SCLC cohort of a single-arm lurbinectedin trial to a ne
Externí odkaz:
https://doaj.org/article/402de053a3ce47b2bcc73a0d834d1e7e
Autor:
Apar Kishor Ganti, Patricia Prince, Xue Wang, Adina Estrin, Anne Boccuti, Badri Rengarajan, Navit Naveh, Ralph D'Agostino, Trevor Alvord, Rami Ben-Joseph
Publikováno v:
Journal of Clinical Oncology. 40:e20619-e20619
e20619 Background: Lurbinectedin monotherapy is currently approved for the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy based on the results of a single-arm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42accf6a784144d1c7b3817eb7b6eb37
https://doi.org/10.1200/jco.2022.40.16_suppl.e20619
https://doi.org/10.1200/jco.2022.40.16_suppl.e20619
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 1:s18
Not Available Disclosures: Study supported by AbbVie.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94ff6f09cfa2a6efe6fd74b19f547bce
https://doi.org/10.25251/skin.1.supp.17
https://doi.org/10.25251/skin.1.supp.17